Showing 2141-2150 of 4166 results for "".
- Vision Expo Announces Virtual EYE2EYE Series Topics for Augusthttps://modernod.com/news/vision-expo-announces-virtual-eye2eye-series-topics-for-august/2478126/Vision Expo announced the upcoming Virtual EYE2EYE Series topics scheduled for August. August 5: SHE Did That! Dr. Danielle Richardson, Optometrist and Founder at Fierce Clarity, will explore the passionate pursuits of Black women in eyecare and their entrepreneurshi
- Midwest Vision Partners Announces Partnership with Specialty Eye Institutehttps://modernod.com/news/midwest-vision-partners-announces-partnership-with-specialty-eye-institute/2477268/Midwest Vision Partners (MVP), an eye care management services organization backed by private equity firm Alpine Investors, has announced its partnership with Specialty Eye Institute (SEI). Terms
- Ash Attia Becomes News CEO of Bionic Vision Technologieshttps://modernod.com/news/ash-attia-becomes-news-ceo-of-bionic-vision-technologies/2476797/Bionic Vision Technologies (BVT) has announced that Ash Attia has been named Chief Executive Officer (CEO), effective July 22. This appointment rounds comes shortly after the appointment of Brian Gordon as Chie
- Pentosan Polysulfate Sodium Treatment Strongly Linked With Maculopathy and Vision Losshttps://modernod.com/news/pentosan-polysulfate-sodium-treatment-strongly-linked-with-maculopathy-and-vision-loss/2476563/Patients taking pentosan polysulfate sodium (PPS), which has been on the market for many years, appear to be at greater risk for a newly described maculopathy and vision loss, researchers report, according to Reuters. “Exposu
- Atia Vision Closes $20M In Series D Financing to Fund Accommodating IOLhttps://modernod.com/news/atia-vision-closes-20m-in-series-d-financing-to-fund-accommodating-iol/2476533/Atia Vision, a Shifamed portfolio company developing a modular presbyopia-correcting accommodating IOL, announced initial closing of its committed $20 million Series D preferred stock
- Common Glaucoma Visual Test Lacks Consideration for Central Vision Losshttps://modernod.com/news/common-glaucoma-visual-test-lacks-consideration-for-central-vision-loss/2476195/A common visual field test used to assess severity of glaucoma—the 24-2 visual field (VF) test—may be underestimating the severity of vision loss in many patients, according to a recent study, as reported by
- American Vision Partners Announces Partnership With Las Vegas’ Abrams Eye Institutehttps://modernod.com/news/american-vision-partners-announces-partnership-with-las-vegas-abrams-eye-institute/2476225/American Vision Partners, an eyecare practice management organization, has established a partnership with Las Vegas-based Abrams Eye Institute, marking its initial move into the Nevada market, according to an announcement this week, as
- Wills Eye Hospital Announces $5 Million Gift for Vision Researchhttps://modernod.com/news/wills-eye-hospital-announces-5-million-gift-for-vision-research/2480046/Wills Eye Hospital has announced that a gift of $5 million has been made to the hospital by philanthropists Vickie and Jack Farber to create the Vickie and Jack Farber Vision Research Center at Wills Eye. The gift builds on their
- RightEye Unveils EyeQ Trainer Personalized Computer-Based Vision Training Systemhttps://modernod.com/news/righteye-unveils-eyeq-trainer-personalized-computer-based-vision-training-system/2480076/RightEye unveiled its new EyeQ Trainer computer-based vision rehabilitation program at Optometry’s Meeting 2018 in Denver, Colorado (RightEye booth #611). EyeQ Trainer gives optometrists a tool their
- Vision Advocates Rally to Defend National Eye Institute from Funding Cuts and Consolidation Threatshttps://modernod.com/news/vision-advocates-rally-to-defend-national-eye-institute-from-funding-cuts-and-consolidation-threats/2482913/Vision science and eye care organizations are mobilizing efforts to combat proposals circulating in Washington to slash federal vision funding and consolidate the National Eye Institute (NEI) into a broader institute on brain and dental research.